CA-125: An evolving role in the management of ovarian cancer

Journal of Clinical Oncology

Volumn 14, Issue 5, 1996, Pages 1411-1412

  Markman, Maurie ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; TUMOR MARKER;

BLOOD LEVEL; CANCER CHEMOTHERAPY; EDITORIAL; HUMAN; OVARY CANCER; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0029862921     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.5.1411     Document Type: Editorial

References (0)